ภูมิคุ้มกันสำเร็จรูป Nirsevimab ตัวช่วยใหม่! ป้องกัน RSV ในทารกและเด็กเล็ก

RSV or Respiratory Syncytial Virus is a harmful virus that can cause severe illness in infants and young children, especially pneumonia and bronchiolitis. There is now a ready-made immunity, nirsevimab, that effectively protects babies from RSV infection.
&nbsp;
<h2>What is Nirsevimab?</h2>
Nirsevimab is a synthetic antibody against RSV to specifically prevent RSV infection.
<h2> 
Advantages of the ready-made immunity Nirsevimab</h2>
<ul>
<li>Reduces the chance of RSV infection by 79.5%</li>
<li>Reduces the risk of hospitalization by 83.2%</li>
<li>Reduces the risk of needing mechanical ventilation by 75.3%</li>
<li>Only one injection per epidemic season (from June to November)</li>
<li>Nirsevimab is suitable for high-risk groups, including newborns up to 1 year old and children aged 1-2 years</li>
<li>Provides long-lasting protection for up to 5 months, covering the RSV epidemic period during late rainy and early winter seasons</li>
</ul>
&nbsp;
<h2>Who should receive Nirsevimab?</h2>
<ul>
<li style="font-weight: 400">Newborns up to 12 months old</li>
<li style="font-weight: 400">Children aged 12 – 24 months who are at high risk, such as those with chronic lung disease, congenital heart disease, and immunodeficiency</li>
</ul>
&nbsp;
<h2>Safety and Side Effects</h2>
<ul>
<li style="font-weight: 400">Side effects are rare, mostly pain, swelling, or redness at the injection site (less than 1%)</li>
<li style="font-weight: 400">Low-grade fever or rash may occur slightly (less than 1%)</li>
<li style="font-weight: 400">Severe allergic reactions are very rare</li>
<li style="font-weight: 400">No serious side effects were found in research studies</li>
</ul>
&nbsp;
Contraindications
<ul>
<li style="font-weight: 400">Children who have had a severe allergic reaction to nirsevimab</li>
<li style="font-weight: 400">Not recommended for treating existing RSV infection (for prevention only)</li>
<li style="font-weight: 400">Not recommended to repeat injection in the same season</li>
</ul>
&nbsp;
Even if your child has had an RSV infection before, it is still recommended to receive nirsevimab to prevent reinfection because natural immunity from infection is usually not permanent, and young children remain at risk of severe illness.

RSV or Respiratory Syncytial Virus is a harmful virus that can cause severe illness in infants and young children, especially pneumonia and bronchiolitis.

Services

Article

About Us

Hospital locations

Passive Immunity Nirsevimab, a New Helper! Preventing RSV in Infants and Young Children

Tel

Email

Services

Article

About Us

Hospital locations